Category Archives: R&D / Quality

TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine, today is pleased to announce its participation in the Innovative Medicines Initiative (IMI) project “Be The CURE”.EN. TcLand Expression est heureux d’annoncer sa participation au projet “Be The Cure”, … Continue reading →

TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient TcLand Expression annonce la mise en place de « PRINT », étude clinique internationale de validation de son … Continue reading →

TcLand Expression appoints its Scientific and Medical Advisory Board dedicated to Rheumatology TcLand Expression annonce la création de son Conseil Scientifique et Médical dédié à la rhumatologie

TcLand Expression initiates major partnership with the Hospital Vall d’Hebron Research Institute and gets exclusive rights on key intellectual property in the field of novel biomarkers in rheumatoid arthritis. EN. FR.

TcLand Expression signs a collaboration agreement with the Hospices Civils de Lyon hospital group for the development of novel biomarkers in rheumatoid arthritis. EN. FR.

TcLand Expression’s Liver graft Tolerance eXpression (L-Tol-X) invitro molecular diagnostic blood test interim clinical data to be presented at the American Transplant Congress (ATC) in San Diego, from May 1st to 5th, 2010. EN. FR.

TcLand Expression, a global leader in the field of gene expression biomarkers and companion diagnostics in immunology, today announced that it had achieved ISO 13485:2003 compliance of its quality management system and renewal of its existing ISO 17025:2005 accreditation. EN. … Continue reading →